CurrentEndo
Get Weekly

CurrentEndo coverage · page 21 of 33

Cardiovascular Diabetology

Briefs 801–840 of 1,291 CurrentEndo has covered from this journal, newest publication first

Latest from Cardiovascular Diabetology

All coverage, newest first

  1. Cardiovasc Diabetol

    Trends in direct health care costs among US adults with atherosclerotic cardiovascular disease with and without diabetes

    Cross-sectional studyT2D & other

  2. Cardiovasc Diabetol

    Association between atherogenic index of plasma and gestational diabetes mellitus: a prospective cohort study based on the Korean population

    Secondary analysisDiabetes in pregnancy

  3. Cardiovasc Diabetol

    Excessive accumulation of epicardial adipose tissue promotes microvascular obstruction formation after myocardial ischemia/reperfusion through modulating macrophages polarization

    Mechanistic studyT2D & other

  4. Cardiovasc Diabetol

    Aggravating effect of abnormal low-density protein cholesterol level on coronary atherosclerotic plaque in type 2 diabetes mellitus patients assessed by coronary computed tomography angiography

    Cross-sectional studyT2D & other

  5. Cardiovasc Diabetol

    Associations of metabolic changes and polygenic risk scores with cardiovascular outcomes and all-cause mortality across BMI categories: a prospective cohort study

    Cohort studyObesity

  6. Cardiovasc Diabetol

    Protein glycation products associate with progression of kidney disease and incident cardiovascular events in individuals with type 1 diabetes

    Cohort studyT1D

  7. Cardiovasc Diabetol

    Artificial sweeteners and risk of incident cardiovascular disease and mortality: evidence from UK Biobank

    Cohort studyT2D & other

  8. Cardiovasc Diabetol

    Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease

    Cohort studyLipids & liver

  9. Cardiovasc Diabetol

    Nonpharmacological interventions on glycated haemoglobin in youth with type 1 diabetes: a Bayesian network meta-analysis

    Meta-analysisT1D

  10. Cardiovasc Diabetol

    Impaired GK-GKRP interaction rather than direct GK activation worsens lipid profiles and contributes to long-term complications: a Mendelian randomization study

    Diagnostic or prognostic studyLipids & liver

  11. Cardiovasc Diabetol

    Nonlinear association between atherogenic index of plasma and type 2 diabetes mellitus in overweight and obesity patients: evidence from Chinese medical examination data

    Cross-sectional studyT2D & other

  12. Cardiovasc Diabetol

    Dual-trajectory of TyG levels and lifestyle scores and their associations with ischemic stroke in a non-diabetic population: a cohort study

    Cohort studyLipids & liver

  13. Cardiovasc Diabetol

    Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial

    Randomized controlled trialT2D & other

  14. Cardiovasc Diabetol

    Sodium-glucose cotransporter 2 inhibitors induce anti-inflammatory and anti-ferroptotic shift in epicardial adipose tissue of subjects with severe heart failure

    Cross-sectional studyT2D & other

  15. Cardiovasc Diabetol

    Empagliflozin’s role in reducing ventricular repolarization heterogeneity: insights into cardiovascular mortality decline from the EMPATHY-HEART trial

    Research articleT2D & other

  16. Cardiovasc Diabetol

    U-shaped association between triglyceride-glucose index and all-cause mortality among critically ill pediatrics: a population-based retrospective cohort study

    Cohort study

  17. Cardiovasc Diabetol

    Assessment of subclinical LV myocardial dysfunction in T2DM patients with diabetic peripheral neuropathy: a cardiovascular magnetic resonance study

    Cross-sectional studyComplications

  18. Cardiovasc Diabetol

    Impact of pretransplant T2DM on left ventricular deformation and myocardial perfusion in heart transplanted recipients: a 3.0 T cardiac magnetic resonance study

    Cross-sectional studyT2D & other

  19. Cardiovasc Diabetol

    Association between atherogenic index of plasma and new-onset stroke in individuals with different glucose metabolism status: insights from CHARLS

    Cohort studyT2D & other

  20. Cardiovasc Diabetol

    Which surrogate insulin resistance indices best predict coronary artery disease? A machine learning approach

    Cohort study

  21. Cardiovasc Diabetol

    Additive effect of admission hyperglycemia on left ventricular stiffness in patients following acute myocardial infarction verified by CMR tissue tracking

    Cross-sectional study

  22. Cardiovasc Diabetol

    Cholesin receptor signalling is active in cardiovascular system-associated adipose tissue and correlates with SGLT2i treatment in patients with diabetes

    Mechanistic studyT2D & other

  23. Cardiovasc Diabetol

    Comparative study on the predictive value of TG/HDL-C, TyG and TyG-BMI indices for 5-year mortality in critically ill patients with chronic heart failure: a retrospective study

    Cohort study

  24. Cardiovasc Diabetol

    Is systemic inflammation a missing link between cardiometabolic index with mortality? Evidence from a large population-based study

    Cohort studyLipids & liver

  25. Cardiovasc Diabetol

    Association of triglyceride-glucose index and its related parameters with atherosclerotic cardiovascular disease: evidence from a 15-year follow-up of Kailuan cohort

    Cohort studyLipids & liver

  26. Cardiovasc Diabetol

    Diabetic foot disease carries an intrinsic high risk of mortality and other severe outcomes in type 2 diabetes: a propensity score-matched retrospective population-based study

    Cohort studyT2D & other

  27. Cardiovasc Diabetol

    Acute-to-chronic glycemic ratio as an outcome predictor in ischemic stroke in patients with and without diabetes mellitus

    Cohort studyT2D & other

  28. Cardiovasc Diabetol

    Weight change and risk of incident type 2 diabetes: short, medium and long-term follow-up in tehran lipid and glucose study

    Cohort studyT2D & other

  29. Cardiovasc Diabetol

    Incident heart failure and the subsequent risk of progression to end stage kidney disease in individuals with type 2 diabetes

    Cohort studyT2D & other

  30. Cardiovasc Diabetol

    Metabolic syndrome parameters' variability and stroke incidence in hypertensive patients: evidence from a functional community cohort

    Cohort study

  31. Cardiovasc Diabetol

    Bidirectional modulation of TCA cycle metabolites and anaplerosis by metformin and its combination with SGLT2i

    Mechanistic studyT2D & other

  32. Cardiovasc Diabetol

    Impact of telemedical management on hospitalization and mortality in heart failure patients with diabetes: a post-hoc subgroup analysis of the TIM-HF2 trial

    Secondary analysisT2D & other

  33. Cardiovasc Diabetol

    Plasma copeptin and markers of arterial disorder in patients with type 2 diabetes, a cross-sectional study

    Cross-sectional studyT2D & other

  34. Cardiovasc Diabetol

    Combined associations of visceral adipose tissue and adherence to a Mediterranean lifestyle with T2D and diabetic microvascular complications among individuals with prediabetes

    Cohort studyT2D & other

  35. Cardiovasc Diabetol

    Dysregulation of long non-coding RNA gene expression pathways in monocytes of type 2 diabetes patients with cardiovascular disease

    Cross-sectional studyT2D & other

  36. Cardiovasc Diabetol

    Dapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure

    Randomized controlled trialT2D & other

  37. Cardiovasc Diabetol

    Nocturnal hypoxemic burden and micro- and macrovascular disease in patients with type 2 diabetes

    Cross-sectional studyT2D & other

  38. Cardiovasc Diabetol

    Association of the TyG index with prognosis in surgical intensive care patients: data from the MIMIC-IV

    Cohort study

  39. Cardiovasc Diabetol

    Insulin resistance assessed by estimated glucose disposal rate and risk of incident cardiovascular diseases among individuals without diabetes: findings from a nationwide, population based, prospective cohort study

    Cohort studyLipids & liver

  40. Cardiovasc Diabetol

    Changes in the combination of the triglyceride-glucose index and obesity indicators estimate the risk of cardiovascular disease

    Cohort studyObesity

All 1,291 Briefs in ExploreShowing Briefs 801–840 of 1,291, newest first